ABSTRACT The diterpene, forskolin [half-maximal effective concentration (EC50), [5] [6] [7] [8] [9] [10] vation of cyclic AMP in rat cerebral cortical slices that is not blocked by a variety of neurotransmitter antagonists. Low concentrations of forskolin (1 ,uM) augment the response of cyclic AMP-generating systems in brain slices to norepinephrine, isoproterenol, histamine, adenosine, prostaglandin E2, and vasoactive intestinal peptide. Forskolin would appear to activate adenylate cyclase through a unique mechanism involving both direct activation of the enzyme and facilitation or potentiation of the modulation of enzyme activity by receptors or the guanyl nucleotide-binding subunit, or both. Cyclic nucleotides regulate many cellular events (1), but it has proven difficult to firmly establish the relationship of cyclic AMP (cAMP) levels to physiological functions in intact cells, tissues, and organisms. In part, this is due to the lack of a satisfactory general activator for adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] in intact cells. Receptor-mediated activation of the enzyme is highly specific and is further dependent on interactions of an intracellular guanyl nucleotide-binding subunit with the catalytic unit of adenylate cyclase (2). Sodium fluoride (3), guanyl nucleotides (4), and divalent cations such as manganese (5, 6) and calcium (7) activate the enzyme independent of specific cell-surface receptors, but fluoride is ineffective with intact cells, and guanyl nucleotides and divalent cations require access to intracellular sites. Cholera toxin and other enterotoxins activate adenylate cyclase both in crude membranes and in intact cells, but the process is irreversible and requires interaction with a ganglioside cell-surface site (8).
(EC50, 25 ,uM) causes a rapid and readily reversible 35-fold elevation of cyclic AMP in rat cerebral cortical slices that is not blocked by a variety of neurotransmitter antagonists. Low concentrations of forskolin (1 ,uM) augment the response of cyclic AMP-generating systems in brain slices to norepinephrine, isoproterenol, histamine, adenosine, prostaglandin E2, and vasoactive intestinal peptide. Forskolin would appear to activate adenylate cyclase through a unique mechanism involving both direct activation of the enzyme and facilitation or potentiation of the modulation of enzyme activity by receptors or the guanyl nucleotide-binding subunit, or both. Cyclic nucleotides regulate many cellular events (1) , but it has proven difficult to firmly establish the relationship of cyclic AMP (cAMP) levels to physiological functions in intact cells, tissues, and organisms. In part, this is due to the lack of a satisfactory general activator for adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] in intact cells. Receptor-mediated activation of the enzyme is highly specific and is further dependent on interactions of an intracellular guanyl nucleotide-binding subunit with the catalytic unit of adenylate cyclase (2) . Sodium fluoride (3), guanyl nucleotides (4), and divalent cations such as manganese (5, 6) and calcium (7) activate the enzyme independent of specific cell-surface receptors, but fluoride is ineffective with intact cells, and guanyl nucleotides and divalent cations require access to intracellular sites. Cholera toxin and other enterotoxins activate adenylate cyclase both in crude membranes and in intact cells, but the process is irreversible and requires interaction with a ganglioside cell-surface site (8) .
The hypotensive (9) diterpene forskolin ( Fig. 1 ) from the roots of Coleus forskohlii (10) has been reported to activate cardiac and brain adenylate cyclase (11, 12 epoxy-la,6,8,9a-trihydroxylabd-14-en-11-one, C22H3407; Mr, 410) was generously provided by Hoechst Pharmaceuticals, Bombay, India. Forskolin is now available from CalBiochemBehring, La Jolla, CA, and has activity equivalent to that reported in this paper for the Hoechst sample. Forskolin (15 mM) was dissolved in 95% ethanol and was stable for at least 4 mo in solution. All other reagents were of the highest quality available from standard commercial sources.
Preparation of Membranes. A male Sprague-Dawley rat (150-175 g) was killed by decapitation, and the brain was removed quickly, chilled briefly in ice-cold Krebs-Ringer bicarbonate/glucose buffer, and placed on a glass plate. Cerebral cortical grey matter was dissected with a razor and homogenized in 50 mM Tris-HCl buffer, pH 7.5/0.1 mM CaCl2 (5 ml per rat cortex) in a Dounce homogenizer (10 strokes substrate, the assay conditions were as described with the exception that no creatine phosphate/creatine kinase regenerating system was used. Assays were initiated by the addition of 25 ,ul of membrane suspension to assay tubes that had been prewarmed at 37°C for 1 min. Assays were carried out at 37°C for 10 min and were terminated with 0.5 ml of 10% (wt/vol) trichloroacetic acid. Carrier cAMP (250 ,ul of 2 mM cAMP) was added, the mixture was centrifuged, and cAMP in the supernatant was isolated and analyzed by the method of Salomon et al. (15) cell preparations result in a virtual irreversible activation of the enzyme (8, 16, 19) .
When adenylate cyclase assays are carried out with ATP and nucleotide-regenerating systems, GTP is formed from endogenous guanyl nucleotides, making it difficult to assess the requirement of GTP for hormonal activation of the enzyme (20 (Fig. 3) (Fig. 3) .
The response to maximal stimulatory concentrations of forskolin (100 pM) and fluoride (10 mM) ofresponses to forskolin by p[NH]ppG (Table 1) contrasted with the potentiation ofthe response to 10 ,uM and 100 ,uM forskolin by GTP and GDP ( Fig. 3; unpublished data) . The results for combinations of forskolin and fluoride with ATP as substrate were not as clear as the results were with p[NH]ppA as substrate. Forskolin (10 ,uM) still caused a further activation of the enzyme at both less than maximal and at maximal concentrations of fluoride with ATP as substrate (data not shown). However, the response to the combination of forskolin and fluoride was less than additive with ATP as substrate. The p[NH]ppG activation of adenylate cyclase was maximal at 100 ,uM with ATP as substrate, and forskolin caused no further activation of the enzyme (data not shown) as was the case with p[NH]ppA as substrate (Table 1) . Adenylate cyclase partially activated by p[NH]ppG was, however, further activated by forskolin (data not shown).
Manganese ions are known to block the activation of adenylate cyclases by p[NH]ppG although having little effect on activation by fluoride (6, 22) . When brain adenylate cyclase was assayed with increasing concentrations ofmanganese ions, there was some increase in basal activity of the enzyme, reaching a maximum at 5 mM manganese (Fig. 4) The effect offorskolin and fluoride on the activity ofadenylate cyclase in membranes from a variety of rat tissues was investigated (Table 2 ). Adenylate cyclases of membranes from rat cerebellum, striatum, heart, and liver exhibited a 2-to 4-fold Tissue membranes were prepared and adenylate cyclase was assayed with 0.5 mM ATP and a nucleotide regenerating system. Basal activities were obtained with the standard assay mixture. The concentrations of NaF and forskolin were 10 mM and 100 pM, respectively.
Membranes were added to the reaction mixture at 0C for 10 min, and the assay was initiated at 370C by the addition of the substrate. Incubations were carried out for 10 min. Values are means ± SEM for three determinations.
activation by fluoride and a considerably greater activation by forskolin. In some tissues, the activations with fluoride were significantly greater than the activations elicited by forskolin. These tissues were skeletal muscle, adrenal, pancreas, stomach, and lung. Adenylate cyclases of all tissues examined were significantly activated by forskolin.
Effects of Forskolin on cAMP-Levels in Intact Cells. Forskolin elicited a maximal 35-fold increase in the accumulation of radioactive cAMP in adenine-labeled rat cerebral cortical slices (Table 3 , legend). The forskolin-elicited increase in cAMP levels was dose dependent, with half-maximal effects at about 25 /.M forskolin and maximal effects at 150 AuM. The response to forskolin in brain slices was rapid, reaching a maximum within about 5 min (data not shown), a time course consonant with the ,time for penetration of a small molecule into brain slices (25) . The increasedaccumulation ofcAMP due to forskolin was maintained in brain slices for at least 40 min and was rapidly reversed after washing, with cAMP-levels returning to control values with a half-time of less than 5 min (data not shown). The response to 150 ,M forskolin was not blocked by a variety of antagonists of neuromodulators or neurotransmitters (data not shown). These included the adenosine-antagonist 8-phenyltheophylline (10 PM), the a-adrenergic blocker phentolamine (10 ,uM) , the f3-adrenergic blocker propranolol (10 ,M) , and the histamine antagonists cimetidine (10 ,uM) and diphenhydramine (10 ,M). The local anesthetic tetracaine (100 ,M) had no effect on the response to forskolin. Forskolin at a concentration of 1 uM. caused only a 3-fold accumulation of cAMP, but significantly augmented the accumulations of cAMP elicited by a variety of agents (Table 3) . These agents included amines, such as norepinephrine, isoproterenol and histamine, vasoactive intestinal peptide, adenosine, and prostaglandin E2. In the presence of a potent phosphodiesterase inhibitor, coded ZK 62771 (26) , forskolin still elicited a marked accumulation of cAMP (Table 3) .
DISCUSSION
Forskolin is a unique activator of adenylate cyclase, which can be distinguished from other stimulating agents by a number of (Fig. 3) . Finally, p[NH]ppG activation of rat cerebral cortical adenylate cyclase is completely inhibited by 5 mM manganese, whereas that of forskolin is slightly potentiated (Fig. 4) . Therefore, although p[NH]ppG and forskolin are not additive at their maximal doses, these two activators of adenylate cyclase clearly act through distinct mechanisms. This does not necessarily imply that activation of adenylate cyclase by forskolin does not affect interactions mediated through the guanyl nucleotide-binding subunit. Indeed, the responses to forskolin are affected by guanyl nucleotides, being potentiated by both GTP and GDP (Fig. 3) . Hormonal activation of adenylate cyclase appears to be related to a facilitated exchange of guanyl nucleotides at the guanyl nucleotide-binding subunit (2) . Forskolin appears to augment this hormonal activation not only in brain slices (Table 3) but also in crude membrane homogenates (35) . In toto, the results suggest that forskolin not only activates -adenylate cyclase directly in a guanyl nucleotide-independent manner, but also forskolin in some manner facilitates or potentiates the modulation of the enzyme activity by hormones or guanyl nucleotides, or both.
Forskolin activates adenylate cyclase in all tissues as yet tested. The unique action offorskolin on adenylate cyclase provides a powerful tool for investigation of this complex enzyme. In addition, the ability of forskolin to rapidly and reversibly increase cAMP levels in intact cells and tissues and to augment hormonal responses provides a hitherto unavailable tool for assessing the role of adenylate cyclase and cAMP in cell physiology.
Note Added in Proof. Forskolin will activate a water-soluble adenylate cyclase from rat testes and adenylate cyclase in membranes from the cyc mutant of S49 murine lymphoma cells. These enzymes do not contain a functional guanine nucleotide-binding protein. Thus, forskolin appears to activate adenylate cyclase by direct interactions with the catalytic subunit, and this interaction is not due to a general perturbation of membrane structure.
